CSI Market
Sign In | Register

Abbott Laboratories (ABT) Annual Income Statement

Annual · GAAP · USD millions
Access ABT quarterly income statements →
The data below summarizes Abbott Laboratories's income statement results from Dec 31 2021 to Dec 31 2025, enabling period-by-period comparison of operating performance.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
2025 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax44,328.00
Total Revenue44,328.00
Costs & Expenses
Cost of Goods and Services Sold19,319.00
Gross Profit25,009.00
Selling, Administration, Marketing12,332.00
Depreciation & Amortization1,682.00
Research and Development Expense2,942.00
Total operating costs including COS36,275.00
Operating income / -loss8,053.00
Interest Expense0.00
Net Interest Expense / -Income0.00
Foreign Currency Transaction Gain (Loss), before Tax-50.00
Other loss/ -income-363.00
Total costs & expenses35,862.00
Income & Taxes
Income / -loss before income taxes8,466.00
Income taxes expenses / -benefit1,942.00
Income after income taxes6,524.00
Income / -loss from continuing operations6,524.00
Net income / -loss6,524.00
Income / -loss to shareholder6,500.00
EBIT8,466.00
EBITD9,900.00
EBITDA11,582.00
Earnings Per Share
Basic EPS (excl. extra items)3.73
Basic Net EPS3.73
Basic shares outstanding (Mill. of Units)1,741.00
Diluted Net EPS3.72
Diluted average shares (Mill. of Units)1,748.00
Dividend per share2.40
4 historic quarters locked

Sign in to unlock the full Abbott Laboratories income statement history.

Sign In Create Free Account

About Abbott Laboratories Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: February 20, 2026
  • Original filing: abt-20251231.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.